If you’re a member of the media working on a story about brain health, we can connect you with the experts at Cohen Veterans Bioscience. Please don’t hesitate to contact us.
Cohen Veterans Bioscience
Cohen Veterans Bioscience is a nonprofit 501(c)(3) research organization dedicated to fast-tracking the development of diagnostic tests and personalized therapeutics for the millions of veterans and civilians who suffer the devastating effects of trauma-related and other brain disorders.
Follow Cohen Veterans Bioscience
- Read more
Null Hypothesis is a collaborative initiative dedicated to publishing well-performed replication and negative studies — or studies where the outcomes do not confirm expected results or working hypotheses — via dedicated journal space.
New Study Reveals Brain Circuit Biomarkers to Predict Response to Treatment in Patients with Complex Neuropsychiatric DisordersRead more
Cohen Veterans Bioscience announced findings from a study which generates new evidence in support of a critical brain imaging biomarker, that may help guide people who suffer from post-traumatic stress disorder (PTSD) or major depressive disorder (MDD) towards the most effective treatment.
Global Preclinical Data Forum and European College of Neuropsychopharmacology Announce the Winner of the 2020 Best Negative Data PrizeRead more
The Global Preclinical Data Forum (GPDF), a jointly sponsored U.S. and European initiative, funded by Cohen Veterans Bioscience (CVB) and the European College of Neuropsychopharmacology (ECNP), announced today the winner of the 2020 “Best Negative Data Prize.” The prize is awarded to the researcher or research group whose neuroscience study best exemplifies data where the outcomes do not confirm the expected results or working hypothesis.
- Read more
Cohen Veterans Bioscience announced it is extending its commitment to the brain health of Veterans by supporting the National Association of Veterans Research Education Foundation (NAVREF) and the new VA Office of Research and Development (ORD) led Partnered Research Program (PRP).
- Read more
This prize, which was first launched in 2017, will award €10,000 to the researcher/research group whose publication in neuroscience research best exemplifies data where the results do not confirm the expected outcomes or original hypotheses.